Gurbey O.
- Country
- The Netherlands
- Department
- Internal Medicine
Research Overview
- Stroke prophylaxis with Apixaban in Chronic Kidney Disease stage 5 patients with Atrial fibrillation (SACK)
- Efficacy and Safety of Baxdrostat and Dapagliflozin on Renal and Cardiovascular Outcomes in Chronic Kidney Disease with Hypertension
- Evaluation of Mezagitamab (TAK-079) Efficacy and Safety in Adults with Primary IgA Nephropathy: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial
Data & Insights
Has run more than one trial at 30 of 282 partner sites.
Specializations
Renal Medicine
The investigator specializes in treating complex renal conditions, with particular emphasis on chronic kidney disease (CKD), including advanced stages like CKD stage 5. Their research encompasses therapeutic approaches for patients requiring dialysis treatment.
- CKD Management
- Dialysis Care
- Renal Function Assessment
Their work includes evaluation of kidney function markers and prevention of renal failure progression.
Cardiovascular Medicine
The investigator focuses on cardiovascular complications in renal patients, particularly atrial fibrillation (AF) and its management. Their expertise extends to stroke prophylaxis and prevention of systemic embolism in high-risk patients.
- Atrial Fibrillation Management
- Cardiovascular Risk Prevention
- Anticoagulation Therapy
Their research addresses cardiovascular outcomes in patients with combined renal and cardiac conditions.
Hypertension Management
The investigator has developed expertise in treating hypertension in the context of kidney disease. Their work involves innovative therapeutic approaches for blood pressure control in complex renal patients.
- Blood Pressure Control
- Antihypertensive Therapy
- Cardiovascular Risk Management
Their research explores combination therapies for optimal blood pressure management in CKD patients.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.